Unicycive Therapeutics Share Price (NASDAQ: UNCY)
$4.18
Last updated on
Check the interactive Unicycive Therapeutics Stock chart to analyse performance
Unicycive Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$4.08Today's High:$4.20
2.39%
Downside
Day's Volatility :2.86%
Upside
0.48%
- 52 Weeks Low:$2.8352 Weeks High:$11.00
32.22%
Downside
52 Weeks Volatility :74.25%
Upside
62.0%
Unicycive Therapeutics Stock Returns
Unicycive Therapeutics Inc Key Stats
Check Unicycive Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Unicycive Therapeutics Stock including INR - Dollar returns
The Unicycive Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Unicycive Therapeutics investment value today
Current value as on today
₹1,28,953
Returns
₹28,953
(+28.95%)
Returns from Unicycive Therapeutics Stock
₹23,669 (+23.67%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Unicycive Therapeutics Stock
Global Institutional Holdings in Unicycive Therapeutics Inc
Name
Holdings %
Vivo Capital, LLC
8.06%
Octagon Capital Advisors LP
7.09%
Nantahala Capital Management, LLC
6.66%
Great Point Partners LLC
5.64%
Vanguard Group Inc
4.29%
Logos Global Management LP
3.60%
Analyst Recommendation on Unicycive Therapeutics Stock
Buy
90%Buy
9%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Unicycive Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Unicycive Therapeutics Share Price Target
What analysts predicted
Upside of 1410.17%
Target:
$63.13
Current:
$4.18
Unicycive Therapeutics share price target is $63.13, a slight Upside of 1410.17% compared to current price of $4.18 as per analysts' prediction.
Unicycive Therapeutics Stock Insights
Price Movement
In the last 3 months, UNCY stock has moved down by -29.3%Increasing Revenue
Revenue is up for the last 2 quarters, -271.0K → 568.0K (in $), with an average increase of 147.7% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, 570.0K → -6.44M (in $), with an average decrease of 1231.1% per quarterUNCY vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 47.3%UNCY vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 155.1%
Unicycive Therapeutics Technicals Summary
Sell
Neutral
Buy
Unicycive Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Unicycive Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -1.43% | -20.45% | 30.23% | -37.27% | -92.92% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.0 | NA | NA | -2.6 | -1.32 | -0.51 | NA | 1.16 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $75.4M | -92.92% | 0.0 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Unicycive Therapeutics Inc
Key Management of Unicycive Therapeutics Inc
Important FAQs about investing in UNCY Stock from India :
What is Unicycive Therapeutics share price today?
Unicycive Therapeutics share price today is $4.18 as on at the close of the market. Unicycive Therapeutics share today touched a day high of $4.20 and a low of $4.08.
What is the 52 week high and 52 week low for Unicycive Therapeutics share?
Unicycive Therapeutics share touched a 52 week high of $11.00 and a 52 week low of $2.83. Unicycive Therapeutics stock price today i.e. is closed at $4.18, lower by 62% versus the 52 week high.
How to invest in Unicycive Therapeutics Stock (UNCY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Unicycive Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Unicycive Therapeutics Shares that will get you 0.3589 shares as per Unicycive Therapeutics share price of $4.18 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Unicycive Therapeutics Stock (UNCY) from India?
Indian investors can start investing in Unicycive Therapeutics (UNCY) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Unicycive Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Unicycive Therapeutics share’s latest price of $4.18 as on August 30, 2025 at 1:29 am IST, you will get 2.3923 shares of Unicycive Therapeutics. Learn more about
fractional shares .
What are the returns that Unicycive Therapeutics has given to Indian investors in the last 5 years?
Unicycive Therapeutics stock has given -92.92% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%